Stock screener

AKTS

Conviction 73HealthcareScan · Tue, Sep 8, 2026
Bearish belt hold
AKTS$24.98-7.65%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 301.46K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Aktis Oncology, Inc.Biotechnologywww.aktisoncology.com ↗
Price24.98
Change-7.65%
Gap-2.00%
Rel volume1.35×
Avg volume268.83K
Avg $ vol6.88M
SMA 2025.45
SMA 5025.50
SMA 20017.88
Price vs 50-2.04%
Price vs 200+39.71%
MA stackmixed
50/200 cross—
Supertrendup · 22.77
RSI (14)48
MACD hist0.04
MACD cross—
Stoch %K / %D43 / 69
ADX (14)21
+DI / −DI21 / 19
RSI divergence—
MACD divergence—
ATR %+5.96%
ADR %5.33%
52w high32.23
52w low0.0372
From 52w high-22.49%
Above 52w low+67050.54%
New 52w highNo
SqueezeOn · 1d
Bollinger width16.10%
%B0.39
Donchian pos43.01%
Donchian high27.66
Donchian low22.96
AVWAP (52w high)26.29
vs AVWAP high-5.00%
AVWAP (52w low)7.37
vs AVWAP low+238.92%
OBV trendUp
Chaikin MF (20)0.20
Today vs 20d1.35×
Avg vol (14d)301.46K
Avg vol (20d)268.83K
Avg $ vol (20d)6.88M
Market cap—
RS 3m (vs SPY)+38.92%
RS 6m (vs SPY)+29.26%
RS line new highNo
Trend template7/8
Technical rank73.0
1 week-3.59%
1 month+3.52%
3 months+31.68%
6 months+31.06%
1 year+27904.48%
YTD+11.52%
P/E—
P/B2.99
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current16.33
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target35.80
Target upside32.15%
Analyst ratingBuy
Institutional66.26%
Ent. value1.37B
Revenue3.38M
Net income-24.14M
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out53.4M
Employees79
ListedFri, Jan 9, 2026
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank73.0 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish belt hold
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 12
    1 scan
  2. Breaking out now
    Jun 15 – Jun 16
    2 scans
  3. Broke out
    Jun 18 – Jun 22
    2 scans

Congress activity

Disclosed STOCK Act trades in AKTS

All disclosures →
No recent disclosed trades by Congress in AKTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKTS · 2 buys · 8 sells

InsiderSideShares
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Exercise50K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell14.8K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell30.83K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell4.37K
Czibere Akos
Chief Medical Officer · Stock Option (Right to Buy) · 2026-07-08
Exercise50K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Exercise50K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell15.8K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell30K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell4.2K
Ron-Bigger Shulamit
Chief Operating Officer · Stock Option (Right to Buy) · 2026-07-08
Exercise50K

SEC filings

EDGAR filings in AKTS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.